items,Q4 2021,Q1 2022,Q2 2022,Q3 2022,ticker
Cash & Equivalents,"6,848","5,048","2,873","3,027",MRNA
Short Term Investments,"3,879","5,067","5,024","5,321",MRNA
Cash and Short Term Invs,"10,727","10,115","7,897","8,348",MRNA
"Trade Accts Recvble, Net","3,175","3,173","2,691","2,695",MRNA
Other Receivables,121,191,153,126,MRNA
"Total Receivables, Net","3,296","3,364","2,844","2,821",MRNA
Invent. - Finished Goods,233,357,142,170,MRNA
Invent. - Work In Progress,338,513,379,366,MRNA
Invent. - Raw Materials,870,"1,072","1,400","1,541",MRNA
Total Inventory,"1,441","1,942","1,921","2,077",MRNA
Prepaid Expenses,531,858,767,889,MRNA
"Other Curr. Assets, Total",76,71,134,162,MRNA
Total Current Assets,"16,071","16,350","13,563","14,297",MRNA
Buildings,313,353,365,388,MRNA
Machinery/Equipment,200,205,226,270,MRNA
Construction in Progress,212,247,284,338,MRNA
Other Prop./Plant/Equip.,"1,010","1,099","1,037","1,716",MRNA
Prop./Plant/Equip. - Gross,"1,735","1,904","1,912","2,712",MRNA
Accumulated Depreciation,(352),(431),(466),(580),MRNA
Prop./Plant/Equip. - Net,"1,383","1,473","1,446","2,132",MRNA
Long Term Investments,"6,843","9,171","10,162","8,655",MRNA
Def. Inc. Tax - LT Asset,326,521,785,920,MRNA
Restricted Cash - LT,12,12,12,14,MRNA
Other Long Term Assets,34,82,75,38,MRNA
Total Assets,"24,669","27,609","26,043","26,056",MRNA
Accounts Payable,302,199,181,330,MRNA
Accrued Expenses,"1,518","1,654","1,818","1,892",MRNA
Notes Payable/ST Debt,0,0,0,0,MRNA
Curr. Port. LT Dbt/Cap Ls.,165,160,121,224,MRNA
Customer Advances,"6,253","5,599","4,093","4,002",MRNA
Income Taxes Payable,876,"1,592",349,66,MRNA
Other Current Liabilities,14,34,250,293,MRNA
"Other Curr. Lblts, Total","7,143","7,225","4,692","4,361",MRNA
Total Current Liabilities,"9,128","9,238","6,812","6,807",MRNA
Total Long Term Debt,599,646,641,922,MRNA
Total Debt,764,806,762,"1,146",MRNA
"Other Liabilities, Total",797,650,605,335,MRNA
Total Liabilities,"10,524","10,534","8,058","8,064",MRNA
Redeemable Preferred Stock,0,0,0,0,MRNA
Common Stock,0,0,0,0,MRNA
Additional Paid-In Capital,"4,211","3,644","2,413","1,488",MRNA
Ret. Earn.(Accum. Deficit),"9,958","13,615","15,812","16,855",MRNA
Unrealized Gain (Loss),--,(211),(283),(406),MRNA
Other Equity,--,0,0,0,MRNA
Other Comprehensive Income,(24),27,43,55,MRNA
"Other Equity, Total",(24),27,43,55,MRNA
Total Equity,"14,145","17,075","17,985","17,992",MRNA
Total Liabilities & Shareholdersâ€™ Equity,"24,669","27,609","26,043","26,056",MRNA
Ttl Comm. Shares Outs.,403,400,392,387,MRNA
Trsy. Shrs-Comm. Primary Iss.,0,0,0,0,MRNA
